Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma

Journal of Investigative Dermatology

Volumn 134, Issue 1, 2014, Pages 176-182

  Laresche, Claire ^a   Pelletier, Fabien ^a,b   Garnache Ottou, Francine ^b,c   Lihoreau, Thomas ^a   Biichlé, Sabeha ^b,c   Mourey, Guillaume ^b,c   Saas, Philippe ^b,c   Humbert, Philippe ^a,b   Seilles, Estelle ^b,c   Aubin, François ^a,b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; PROCOAGULANT;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CANCER PATIENT; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MIDDLE AGED; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THICKNESS;

EID: 84891024941     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.288     Document Type: Article

References (34)

1. Angelot F, Seillès E, Biichlé S et al. (2009) Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica 94: 1502-12
2. Balch CM, Gershenwald JE, Soong S-J et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-206
3. Barry OP, Kazanietz MG, Praticò D et al. (1999) Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 274: 7545-56
4. Brill A, Dashevsky O, Rivo J et al. (2005) Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 67: 30-8
5. Castellana D, Toti F, Freyssinet J-M (2010) Membrane microvesicles: macromessengers in cancer disease and progression. Thromb Res 125(Suppl 2): S84-8
6. Chironi GN, Boulanger CM, Simon A et al. (2009) Endothelial microparticles in diseases. Cell Tissue Res 335: 143-51
7. Davila M, Amirkhosravi A, Coll E et al. (2008) Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6: 1517-24
8. Dvorak HF, Van DeWater L, Bitzer AM et al. (1983) Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 43: 4434-42
9. Helley D, Banu E, Bouziane A et al. (2009) Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 56: 479-84
10. Italiano JE Jr, Mairuhu ATA, Flaumenhaft R (2010) Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 17: 578-84
11. Kim HK, Song KS, Park YS et al. (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39: 184-91
12. Kim HK, Song KS, Chung JH et al. (2004) Platelet microparticles induce angiogenesis in vitro. Br J Haematol 124: 376-84
13. Lacroix R, Judicone C, Poncelet P et al. (2012) Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 10: 437-46
14. Lacroix R, Sabatier F, Mialhe A et al. (2007) Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 110: 2432-9
15. Leroyer AS, Anfosso F, Lacroix R et al. (2010) Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 104: 456-63
16. Lima LG, Chammas R, Monteiro RQ et al. (2009) Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine- dependent manner. Cancer Lett 283: 168-75
17. Lima LG, Oliveira AS, Campos LC et al. (2011) Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thromb Haemost 106: 712-23
18. Martinez MC, Kunzelmann C, Freyssinet JM et al. (2004) Remodelage de la membrane plasmique et stimulation cellulaire. Med Sci 20: 189-95
19. Martínez MC, Larbret F, Zobairi F et al. (2006) Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood 108: 3012-20
20. Pelletier F, Garnache-Ottou F, Angelot F et al. (2011) Increased levels of circulating endothelial-derived microparticles and small-size plateletderived microparticles in psoriasis. J Invest Dermatol 131: 1573-6
21. Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6: 401-10
22. Rak J (2010) Microparticles in cancer. Semin Thromb Hemost 36: 888-906
23. Rank A, Liebhardt S, Zwirner J et al. (2012a) Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Res 32: 2009-14
24. Rank A, Nieuwland R, Roesner S et al. (2012b) Climacteric lowers plasma levels of platelet-derived microparticles: a pilot study in pre- versus postmenopausal women. Acta Haematol 128: 53-9
25. Robert S, Poncelet P, Lacroix R et al. (2009) Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 7: 190-7
26. Sabatier F, Lacroix R, Leroyer A-S et al. (2011) Rôle des microparticules cellulaires à l'interfacedes réponses prothrombotiques et inflammatoires. Transfus Clin Biol 18: 62-9
27. Suades R, Padro T, Vilahur G et al. (2012) Circulating and platelet-derived microparticles in human blood enhance thrombosis on athrosclerotic plaques. Thromb Haemost 108: 1208-19
28. Tas F, Ciftci R, Kilic L et al. (2012) Clinical and pronostic signifiance of coagulation assays in melanoma. Melanoma Res 22: 368-75
29. Thaler J, Ay C, Mackman N et al. (2012) Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 10: 1363-70
30. Théry C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9: 581-93
31. Toth B, Nieuwland R, Liebhardt S et al. (2008) Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res 28: 1107-12
32. Varon D, Shai E (2009) Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 8: 237-41
33. Wieckowski EU, Visus C, Szajnik M et al. (2009) Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumorreactive activated CD8+ T lymphocytes. J Immunol 183: 3720-30
34. Zernecke A, Bidzhekov K, Noels H et al. (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2:ra81